Search Results - "Esch, Robert E."

Refine Results
  1. 1

    Fungal raw materials used to produce allergen extracts by Esch, Robert E., PhD, Codina, Rosa, PhD

    Published in Annals of allergy, asthma, & immunology (01-04-2017)
    “…Abstract Objective To review the topic of fungal raw materials used for the production of allergen extracts and the associated challenges and highlight…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Mite allergen extracts and clinical practice by Carnés, Jerónimo, PhD, Iraola, Víctor, PhD, Cho, Seong H., MD, Esch, Robert E., PhD

    Published in Annals of allergy, asthma, & immunology (01-03-2017)
    “…Abstract Objective To provide physicians, researchers, and other interested health care professionals with information about how mite source materials and…”
    Get full text
    Journal Article
  4. 4

    Allergen immunotherapy: What can and cannot be mixed? by Esch, Robert E., PhD

    Published in Journal of allergy and clinical immunology (01-09-2008)
    “…In some cases, increasing the glycerin concentration to 50% significantly increased the stability of the mixture and its shelf-life, but the results are not…”
    Get full text
    Journal Article
  5. 5

    Manufacturing and standardizing fungal allergen products by Esch, Robert E

    Published in Journal of allergy and clinical immunology (01-02-2004)
    “…The importance of fungal allergen products in the practice of clinical allergy is frequently underestimated. A wide variety of fungal species have been…”
    Get full text
    Book Review Conference Proceeding Journal Article
  6. 6

    Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes by Cox, Linda, MD, Esch, Robert E., PhD, Corbett, Mark, MD, Hankin, Cheryl, PhD, Nelson, Michael, MD, PhD, Plunkett, Greg, PhD

    Published in Annals of allergy, asthma, & immunology (01-10-2011)
    “…To discuss recent issues pertinent to allergen immunotherapy practice in the United States. Allergen extract preparation guidelines, updated allergen…”
    Get full text
    Journal Article
  7. 7

    Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen by Skoner, David, MD, Gentile, Deborah, MD, Bush, Robert, MD, Fasano, Mary Beth, MD, McLaughlin, Anne, MD, Esch, Robert E., PhD

    Published in Journal of allergy and clinical immunology (01-03-2010)
    “…Background Specific allergen immunotherapy is most often delivered subcutaneously, but sublingual immunotherapy may confer greater benefit in terms of…”
    Get full text
    Journal Article
  8. 8

    Evaluation and Interpretation of the Purity of Pollen Used to Manufacture Allergen Extracts by Codina, Rosa, PhD, FAAAAI, Crenshaw, Rodger C., MS, Esch, Robert E., PhD, FAAAAI

    Published in Journal of allergy and clinical immunology (01-02-2017)
    “…Pollen grains with uncommon morphologies and disruptions, large numbers of miscellaneous fungal spores, presence of aggregated small (<4mm) spores, unusual…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Allergen stabilities and compatibilities in mixtures of high-protease fungal and insect extracts by Grier, Thomas J., PhD, LeFevre, Dawn M., BS, Duncan, Elizabeth A., BS, Esch, Robert E., PhD, Coyne, Terrance C., MD

    Published in Annals of allergy, asthma, & immunology (01-06-2012)
    “…Abstract Background Current practice guidelines state that protease-rich fungal and insect extracts can be combined when preparing immunotherapy vaccines, but…”
    Get full text
    Journal Article
  12. 12

    Allergen Compatibilities in Extract Mixtures by Esch, Robert E., PhD, Grier, Thomas J., PhD

    “…Stability studies with a few well-characterized allergen extracts have yielded useful information about the shelf-life of these products stored under various…”
    Get full text
    Journal Article
  13. 13

    Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus by Reap, Elizabeth A, Morris, John, Dryga, Sergey A, Maughan, Maureen, Talarico, Todd, Esch, Robert E, Negri, Sarah, Burnett, Bruce, Graham, Andrew, Olmsted, Robert A, Chulay, Jeffrey D

    Published in Vaccine (16-10-2007)
    “…Abstract We used a replication-incompetent, single-cycle, alphavirus replicon vector system to produce virus-like replicon particles (VRP) expressing the…”
    Get full text
    Journal Article
  14. 14

    Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results by Esch, Robert E., PhD, Bush, Robert K., MD, Peden, David, MD, Lockey, Richard F., MD

    Published in Annals of allergy, asthma, & immunology (01-05-2008)
    “…Background European studies provide a preponderance of evidence for sublingual allergen immunotherapy (SLIT) safety and efficacy, but they use allergen…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Understanding differences in allergen immunotherapy products and practices in North America and Europe by Mahler, Vera, Esch, Robert E., Kleine-Tebbe, Jörg, Lavery, William J., Plunkett, Greg, Vieths, Stefan, Bernstein, David I.

    Published in Journal of allergy and clinical immunology (01-03-2019)
    “…Allergen immunotherapy (AIT) is thought to be clinically effective and safe in treating allergic rhinitis, asthma, and stinging insect allergy in Europe and…”
    Get full text
    Journal Article
  17. 17

    Stability of standardized grass, dust mite, cat, and short ragweed allergens after mixing with mold or cockroach extracts by Grier, Thomas J., PhD, LeFevre, Dawn M., BS, Duncan, Elizabeth A., BS, Esch, Robert E., PhD

    Published in Annals of Allergy, Asthma & Immunology (01-08-2007)
    “…Background Limited data are available on the immunochemical compatibilities of standardized and nonstandardized allergen extracts in immunotherapy vaccines…”
    Get full text
    Journal Article
  18. 18

    Stability and mixing compatibility of dog epithelia and dog dander allergens by Grier, Thomas J., PhD, LeFevre, Dawn M., BS, Duncan, Elizabeth A., BS, Esch, Robert E., PhD

    Published in Annals of allergy, asthma, & immunology (01-11-2009)
    “…Background Little information or data are available concerning the stability and compatibility of dog epithelia and dog dander allergens. Objective To…”
    Get full text
    Journal Article
  19. 19

    The Clinical Relevance of Pollen Versus Fungal Spores in Allergic Diseases by Codina, Rosa, Esch, Robert E., Lockey, Richard F.

    “…Pollen and fungal spores are associated with seasonal and perennial allergies. However, most scientific literature thus far suggests that pollen allergy is…”
    Get full text
    Journal Article
  20. 20

    Immunotherapy Preparation Guidelines, Rules, and Regulation by Esch, Robert E., Plunkett, Greg A.

    Published in Current allergy and asthma reports (01-08-2013)
    “…Allergen immunotherapy has been used to treat allergic diseases for more than 100 years. In the U.S., the preparation of diagnostic and therapeutic extracts…”
    Get full text
    Journal Article